Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$6.05 - $9.74 $687,885 - $1.11 Million
-113,700 Reduced 77.51%
33,000 $240,000
Q4 2023

Feb 12, 2024

BUY
$3.29 - $6.64 $482,643 - $974,088
146,700 New
146,700 $909,000
Q3 2021

Nov 10, 2021

SELL
$1.27 - $8.17 $36,214 - $232,967
-28,515 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$6.55 - $8.98 $1.6 Million - $2.2 Million
-244,635 Reduced 89.56%
28,515 $216,000
Q1 2021

May 13, 2021

BUY
$6.1 - $7.69 $551,501 - $695,252
90,410 Added 49.47%
273,150 $1.81 Million
Q3 2020

Nov 13, 2020

SELL
$5.25 - $7.08 $21,850 - $29,466
-4,162 Reduced 2.23%
182,740 $960,000
Q2 2020

Aug 14, 2020

BUY
$5.37 - $8.11 $705,945 - $1.07 Million
131,461 Added 237.12%
186,902 $1.29 Million
Q1 2020

May 14, 2020

BUY
$4.35 - $8.79 $241,168 - $487,326
55,441 New
55,441 $315,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $829M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.